TRxADE HEALTH Dividend
Dividend criteria checks 0/6
TRxADE HEALTH does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 1.0% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$9.76 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
TRxADE Health prices of $1.8M stock offering
Oct 05TRxADE Health launches next day delivery services via Trxade prime plus program
Aug 30TRxADE Health proposes public stock offering
Aug 23Trxade Group GAAP EPS of -$0.13 misses by $0.05, revenue of $3.3M beats by $0.37M
Jul 25Will TRxADE HEALTH (NASDAQ:MEDS) Spend Its Cash Wisely?
Mar 30Here's Why We're Watching TRxADE HEALTH's (NASDAQ:MEDS) Cash Burn Situation
Nov 23Need To Know: Analysts Just Made A Substantial Cut To Their TRxADE HEALTH, Inc. (NASDAQ:MEDS) Estimates
Jul 29Pharma Pain Points - Trxade CEO Suren Ajjarapu (Video)
Jun 16SpartanNash and Bonum Health join hands to provide telemedicine services
Jun 07Shareholders Will Probably Hold Off On Increasing Trxade Group, Inc.'s (NASDAQ:MEDS) CEO Compensation For The Time Being
May 22Earnings Release: Here's Why Analysts Cut Their Trxade Group, Inc. (NASDAQ:MEDS) Price Target To US$10.00
Apr 28Time To Worry? Analysts Just Downgraded Their Trxade Group, Inc. (NASDAQ:MEDS) Outlook
Apr 01Did Business Growth Power Trxade Group's (NASDAQ:MEDS) Share Price Gain of 143%?
Feb 05Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if MEDS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MEDS's dividend payments have been increasing.
Dividend Yield vs Market
TRxADE HEALTH Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (MEDS) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Healthcare Services) | 1.0% |
Analyst forecast in 3 Years (MEDS) | n/a |
Notable Dividend: Unable to evaluate MEDS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MEDS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate MEDS's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as MEDS has not reported any payouts.